Advertisement

Vitamin K and the Immune System

Chapter

Abstract

Vitamin K is one of the fat-soluble vitamins with two natural types, phylloquinone (K1) and menaquinone (K2), and one synthetic form named menadione (vitamin K3). Vitamin K plays key roles in different physiological functions such as blood coagulation, bone metabolism, and the regulation of some enzyme systems. It can also act as a cofactor for some plasma proteins, thereby affecting immune and inflammatory responses particularly mediated by T cells. Studies have found links between vitamin K levels and diseases, including inflammatory diseases and cancer. However, there is limited information about how the immune and inflammatory responses can be influenced by vitamin K. Further studies are necessary to clarify the roles of vitamin K on the immune system.

Keywords

Immunity Inflammation T cells Vitamin K 

References

  1. 1.
    Ohsaki Y, Shirakawa H, Hiwatashi K, Furukawa Y, Mizutani T, Komai M. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem. 2006;70(4):926–32.CrossRefGoogle Scholar
  2. 2.
    Kathleen Mahan L, Escott-Stump S, Raymond JL, Marie V. Krause’s food & the nutrition care process. Chapter 3: Intake: the nutrients and their metabolism; 2012. p. 72–3.Google Scholar
  3. 3.
    Tanaka S, Nishiumi S, Nishida M, Mizushina Y, Kobayashi K, Masuda A, et al. Vitamin K3 attenuates lipopolysaccharide-induced acute lung injury through inhibition of nuclear factor-κB activation. Clin Exp Immunol. 2010;160(2):283–92.CrossRefGoogle Scholar
  4. 4.
    Checker R, Sharma D, Sandur SK, Khan NM, Patwardhan RS, Kohli V, et al. Vitamin K3 suppressed inflammatory and immune responses in a redox-dependent manner. Free Radic Res. 2011;45(8):975–85.CrossRefGoogle Scholar
  5. 5.
    Duan F, Yu Y, Guan R, Xu Z, Liang H, Hong L. Vitamin K2 induces mitochondria-related apoptosis in human bladder cancer cells via ROS and JNK/p38 MAPK signal pathways. PLoS One. 2016;11(8):e0161886.CrossRefGoogle Scholar
  6. 6.
    Hatanaka H, Ishizawa H, Nakamura Y, Tadokoro H, Tanaka S, Onda K, et al. Effects of vitamin K 3 and K 5 on proliferation, cytokine production, and regulatory T cell-frequency in human peripheral-blood mononuclear cells. Life Sci. 2014;99(1):61–8.CrossRefGoogle Scholar
  7. 7.
    Shea MK, Booth SL, Massaro JM, Jacques PF, D’Agostino RB Sr, Dawson-Hughes B, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2007;167(3):313–20.CrossRefGoogle Scholar
  8. 8.
    Karacabey K, Ozdemir N. The effect of nutritional elements on the immune system. J Obes Weight Loss Ther. 2012;2:152.CrossRefGoogle Scholar
  9. 9.
    Blom AM, Villoutreix BO, Dahlbäck B. Complement inhibitor C4b-binding protein—Friend or foe in the innate immune system? Mol Immunol. 2004;40(18):1333–46.CrossRefGoogle Scholar
  10. 10.
    Shea MK, Dallal GE, Dawson-Hughes B, Ordovas JM, O’donnell CJ, Gundberg CM, et al. Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr. 2008;88(2):356–63.CrossRefGoogle Scholar
  11. 11.
    Nakajima S, Iijima H, Egawa S, Shinzaki S, Kondo J, Inoue T, et al. Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease. Nutrition. 2011;27(10):1023–8.CrossRefGoogle Scholar
  12. 12.
    Dasari S, Ali SM, Zheng G, Chen A, Dontaraju VS, Bosland MC, et al. Vitamin K and its analogs: potential avenues for prostate cancer management. Oncotarget. 2017;8(34):57782.CrossRefGoogle Scholar
  13. 13.
    Yoshida T, Miyazawa K, Kasuga I, Yokoyama T, Minemura K, Ustumi K, et al. Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. Int J Oncol. 2003;23(3):627–32.PubMedGoogle Scholar
  14. 14.
    Miyazawa K, Yaguchi M, Funato K, Gotoh A, Kawanishi Y, Nishizawa Y, et al. Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells. Leukemia. 2001;15(7):1111.CrossRefGoogle Scholar
  15. 15.
    Wei G, Wang M, Hyslop T, Wang Z, Carr BI. Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo. Int J Cancer. 2010;127(12):2949–58.CrossRefGoogle Scholar
  16. 16.
    Samykutty A, Shetty AV, Dakshinamoorthy G, Kalyanasundaram R, Zheng G, Chen A, et al. Vitamin k2, a naturally occurring menaquinone, exerts therapeutic effects on both hormone-dependent and hormone-independent prostate cancer cells. Evid Based Complement Alternat Med. 2013;2013:287358.CrossRefGoogle Scholar
  17. 17.
    Park GB, Kim YS, Lee H-K, Song H, Kim S, Cho D-H, et al. Reactive oxygen species and p38 MAPK regulate Bax translocation and calcium redistribution in salubrinal-induced apoptosis of EBV-transformed B cells. Cancer Lett. 2011;313(2):235–48.CrossRefGoogle Scholar
  18. 18.
    Shibayama-Imazu T, Sonoda I, Sakairi S, Aiuchi T. Ann W-w, Nakajo S et al. production of superoxide and dissipation of mitochondrial transmembrane potential by vitamin K 2 trigger apoptosis in human ovarian cancer TYK-nu cells. Apoptosis. 2006;11(9):1535–43.CrossRefGoogle Scholar
  19. 19.
    Yang C-R, Liao W-S, Wu Y-H, Murugan K, Chen C, Chao J-I. CR108, a novel vitamin K3 derivative induces apoptosis and breast tumor inhibition by reactive oxygen species and mitochondrial dysfunction. Toxicol Appl Pharmacol. 2013;273(3):611–22.CrossRefGoogle Scholar
  20. 20.
    Logue SE, Martin SJ. Caspase activation cascades in apoptosis. Biochem Soc Trans. 2008;36(1):1–9.CrossRefGoogle Scholar
  21. 21.
    Karasawa S, Azuma M, Kasama T, Sakamoto S, Kabe Y, Imai T, et al. Vitamin K2 covalently binds to Bak and induces Bak-mediated apoptosis. Mol Pharmacol. 2013;83(3):613–20.CrossRefGoogle Scholar
  22. 22.
    Tamori A, Habu D, Shiomi S, Kubo S, Nishiguchi S. Potential role of vitamin K2 as a chemopreventive agent against hepatocellular carcinoma. Hepatol Res. 2007;37(s2):S303–7.CrossRefGoogle Scholar
  23. 23.
    Chu K-J, Lai EC, Yao X-P, Zhang H-W, Lau WY, Fu X-H, et al. Vitamin analogues in chemoprevention of hepatocellular carcinoma after resection or ablation—a systematic review and meta-analysis. Asian J Surg. 2010;33(3):120–6.CrossRefGoogle Scholar
  24. 24.
    Riaz IB, Riaz H, Riaz T, Rahman S, Amir M, Badshah MB, et al. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2012;12(1):170.CrossRefGoogle Scholar
  25. 25.
    Zhong J-H, Mo X-S, Xiang B-D, Yuan W-P, Jiang J-F, Xie G-S, et al. Postoperative use of the chemopreventive vitamin K2 analog in patients with hepatocellular carcinoma. PLoS One. 2013;8(3):e58082.CrossRefGoogle Scholar
  26. 26.
    Yokoyama T, Miyazawa K, Naito M, Toyotake J, Tauchi T, Itoh M, et al. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy. 2008;4(5):629–40.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesTehranIran
  2. 2.Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesTehranIran
  3. 3.Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical SciencesTehranIran
  4. 4.Dietetics and Nutrition Experts Team (DiNET), Universal Scientific Education and Research Network (USERN)TehranIran

Personalised recommendations